Robin Sherrington
Corporate Officer/Principal chez XENON PHARMACEUTICALS INC.
Fortune : 336 760 $ au 30/04/2024
Profil
Robin Sherrington currently works at Xenon Pharmaceuticals, Inc., as Executive Vice President-Strategy & Innovation from 2019.
Dr. Sherrington also formerly worked at Pfizer Inc., as Neuroscience Director from 1999 to 2001, Sequana Therapeutics, Inc., as Neuroscience Director from 1996 to 1999, Axys Pharmaceuticals, Inc., as Neuroscience Director from 1996 to 1999, and Parke-Davis & Co. Ltd., as Neuroscientist.
Dr. Sherrington received his undergraduate degree from The University of Reading and doctorate degree from University College London.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
05/04/2024 | 8 398 ( 0,01% ) | 336 760 $ | 30/04/2024 |
Postes actifs de Robin Sherrington
Sociétés | Poste | Début |
---|---|---|
XENON PHARMACEUTICALS INC. | Corporate Officer/Principal | 01/03/2019 |
Anciens postes connus de Robin Sherrington
Sociétés | Poste | Fin |
---|---|---|
PFIZER, INC. | Corporate Officer/Principal | 01/01/2001 |
Axys Pharmaceuticals, Inc.
Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/1999 |
Sequana Therapeutics, Inc.
Sequana Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sequana Therapeutics Inc. is a leading genomics company that uses industrial-scale gene-finding technologies and functional genomics to develop products aimed at diagnosing and treating common human diseases | Corporate Officer/Principal | 01/01/1999 |
Parke-Davis & Co. Ltd.
Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The company is based in St. Helier, UK. | Corporate Officer/Principal | - |
Formation de Robin Sherrington
University College London | Doctorate Degree |
The University of Reading | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
XENON PHARMACEUTICALS INC. | Health Technology |
PFIZER, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Axys Pharmaceuticals, Inc.
Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Health Technology |
Sequana Therapeutics, Inc.
Sequana Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sequana Therapeutics Inc. is a leading genomics company that uses industrial-scale gene-finding technologies and functional genomics to develop products aimed at diagnosing and treating common human diseases | Commercial Services |
Parke-Davis & Co. Ltd.
Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The company is based in St. Helier, UK. | Health Technology |